INmune Bio - 53 Year Dividend History | INMB
Historical dividend payout and yield for INmune Bio (INMB) since 1971. The current TTM dividend payout for INmune Bio (INMB) as of April 18, 2024 is $0.00. The current dividend yield for INmune Bio as of April 18, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.160B |
$0.000B |
|
INmune Bio Inc. is a clinical-stage biotechnology company. It engages in developing therapies targeting the innate immune system in cancer. The company's product platform consists of INKmune and INB03. INKmune is a natural killer cell therapeutic which primes the patient's NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio Inc. is based in La Jolla, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
